NORTHWEST BIOTHERAPEUTICS INC Cash and Restricted Cash
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Cash and Restricted Cash of $595.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $595.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.79M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.04M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.56M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $595.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.79M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $3.04M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $4.56M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $4.32M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $2.78M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $2.17M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $2.94M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $2.88M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $2.48M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $2.13M 10-K · filed 2026-04-15 |
| 2023-09-30 | $6.10M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $1.42M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $6.19M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $6.96M 10-K · filed 2025-03-31 |
| 2022-09-30 | $9.43M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $4.83M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $6.96M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $15.17M 10-K · filed 2024-03-05 |
| 2021-09-30 | $3.84M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $3.76M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $7.47M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $9.98M 10-K · filed 2024-03-05 |
| 2019-12-31 | $372.00K 10-K · filed 2023-02-28 |
| 2018-12-31 | $22.22M 10-K · filed 2022-03-01 |
| 2017-12-31 | $117.00K 10-K · filed 2018-04-17 |
| 2017-09-30 | $1.05M 10-Q · filed 2017-11-20 |
| 2016-12-31 | $6.87M 10-K · filed 2018-04-17 |
| 2016-09-30 | $1.49M 10-Q · filed 2017-11-20 |
| 2015-12-31 | $23.05M 10-K · filed 2018-04-17 |